Form D · Biotechnology
Medcura, Inc.
Riverdale, MD · CIK 0001672180
Offering snapshot reported Jul 25, 2025 · SEC filing
- Reported sold
- $28.5M Offering amount: $38.3M
- Investors reported
- 174 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 16, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 25, 2025 | Initial | $28,548,588 | No comparison | 174 | SEC filing |
| Jul 24, 2024 | Amendment | $22,486,953 | $19,279,903vs Aug 16, 2022 | 151 | SEC filing |
| Aug 16, 2022 | Initial | $3,207,050 | No comparison | 26 | SEC filing |
| Nov 2, 2021 | Initial | $3,490,000 | No comparison | 45 | SEC filing |
| Sep 28, 2020 | Initial | $3,021,475 | No comparison | 55 | SEC filing |
| Jul 2, 2018 | Initial | $1,561,500 | No comparison | 36 | SEC filing |
| Nov 10, 2016 | Amendment | $1,072,281 | $979,128vs Sep 20, 2016 | 14 | SEC filing |
| Sep 20, 2016 | Initial | $93,153 | No comparison | 2 | SEC filing |
| Apr 14, 2016 | Initial | $11 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $52.2K
- Form D file number
- 021-552768
Convertible Promissory Notes; Series B Preferred Stock underlying the convertible promissory notes
Source: Form D, filed Jul 25, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Abbas Ardehali, M.D. | Director |
| Alex Arrow | Director |
| Jim Buck | Director, Executive |
| Matthew Dowling | Director, Executive |
| Matthew Dowling, Ph.D | Director, Executive |
| Peter Thomas | Director, Executive |
| Larry Tiffany | Director, Executive |
| Rich Vincent | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5650 Rivertech Court, Suite S
Riverdale, MD, 20737
Phone: 3014053585
Riverdale, MD, 20737
Phone: 3014053585